The PowerPort® implantable port is an implantable access device designed to provide repeated access to the vascular system. Port access is performed by percutaneous needle insertion using a non-coring needle. Power injection is performed using a POWERLOC® Brand Safety Infusion Set* only. The PowerPort® device consists of two primary components: an injection port with a self-sealing silicone septum and a radiopaque catheter. Single lumen PowerPort®implantable ports can be identified subcutaneously by feeling the top of the septum which includes three palpation bumps arranged in a triangle and by palpating the sides of the port, which is also triangular. Dual lumen PowerPort®implantable ports can be identified subcutaneously by feeling the top of each septum; each septum features three palpation bumps arranged in a triangle. All materials are biocompatible, can be used with virtually all injectable solutions intended for medicinal use, including the power injection of contrast media. For implantable ports with GROSHONG® catheters, the GROSHONG® catheter valve helps provide security against blood reflux and air embolism into the port/catheter system. The GROSHONG® catheter may be flushed with normal saline, and it does not require heparin to maintain patency.
The PowerPort® implantable port is indicated for patient therapies requiring repeated access to the vascular system. The port system can be used for infusion of medications, I.V. fluids, parenteral nutrition solutions, blood products, and for the withdrawal of blood samples.
When used with a POWERLOC® Brand Safety Infusion Set*, the PowerPort® device is indicated for power injection of contrast media. For power injection of contrast media, the maximum recommended infusion rate is 5 mL/s.
This device is contraindicated for:
I. During Placement:
II. During Port Access:
I. Prior to Placement:
II. During Placement:
II. After Placement: